menu search

NXTC / NextCure to Present at the JMP Securities Life Sciences Conference

NextCure to Present at the JMP Securities Life Sciences Conference
BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the JMP Securities Life Sciences Conference in New York City on Tuesday, May 16th, at 11:30 am ET. Read More
Posted: May 9 2023, 07:00
Author Name: GlobeNewsWire
Views: 082111

NXTC News  

NextCure to Present at the JMP Securities Life Sciences Conference

By GlobeNewsWire
May 9, 2023

NextCure to Present at the JMP Securities Life Sciences Conference

BELTSVILLE, Md., May 09, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering a more_horizontal


Search within

Pages Search Results: